{"id":1807,"date":"2022-06-06T23:00:02","date_gmt":"2022-06-06T21:00:02","guid":{"rendered":"https:\/\/ctgct.si\/?page_id=1807"},"modified":"2026-09-30T09:06:15","modified_gmt":"2026-09-30T07:06:15","slug":"about-us","status":"publish","type":"page","link":"https:\/\/ctgct.si\/en\/about-us\/","title":{"rendered":"CTGCT, a centre to bridge the gap between research and therapeutic solutions"},"content":{"rendered":"<p>The Centre for the Technologies of Gene and Cell Therapy was funded in September 2024, after the NIC received a grant and the mission to start a project that would focus on creating a pipeline of biomedical tools focused on the development of therapeutic solutions for rare genetic diseases and difficult-to-treat cancers. The CTGCT is an infrastructure center within the NIC and a European Center of Excellence (CoE). The project is funded by the European Union (Project: 101059842 &#8211; CTGCT &#8211; HORIZON-WIDERA-2022), UK Research and Innovation and the Ministry of Higher Education, Science and Innovation &#8211; European Regional Development Fund EU under Slovenia\u2019s Cohesion Policy Programme 2021-2027 (grant agreement No. C3360-25-952005) .<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-5284\" src=\"https:\/\/ctgct.si\/wp-content\/uploads\/2026\/01\/funding-banner-300x46.png\" alt=\"Funding Banner\" width=\"500\" height=\"77\" srcset=\"https:\/\/ctgct.si\/wp-content\/uploads\/2026\/01\/funding-banner-300x46.png 300w, https:\/\/ctgct.si\/wp-content\/uploads\/2026\/01\/funding-banner-1024x157.png 1024w, https:\/\/ctgct.si\/wp-content\/uploads\/2026\/01\/funding-banner-768x118.png 768w, https:\/\/ctgct.si\/wp-content\/uploads\/2026\/01\/funding-banner-1536x236.png 1536w, https:\/\/ctgct.si\/wp-content\/uploads\/2026\/01\/funding-banner-2048x315.png 2048w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Centre for the Technologies of Gene and Cell Therapy was funded in September 2024, after the NIC received a grant and the mission to start a project that would focus on creating a pipeline of biomedical tools focused on the development of therapeutic solutions for rare genetic diseases and difficult-to-treat cancers. The CTGCT is &#8230; <\/p>\n","protected":false},"author":10,"featured_media":2648,"parent":0,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"iawp_total_views":1355,"footnotes":""},"class_list":["post-1807","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/ctgct.si\/en\/wp-json\/wp\/v2\/pages\/1807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ctgct.si\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ctgct.si\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ctgct.si\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/ctgct.si\/en\/wp-json\/wp\/v2\/comments?post=1807"}],"version-history":[{"count":11,"href":"https:\/\/ctgct.si\/en\/wp-json\/wp\/v2\/pages\/1807\/revisions"}],"predecessor-version":[{"id":5859,"href":"https:\/\/ctgct.si\/en\/wp-json\/wp\/v2\/pages\/1807\/revisions\/5859"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ctgct.si\/en\/wp-json\/wp\/v2\/media\/2648"}],"wp:attachment":[{"href":"https:\/\/ctgct.si\/en\/wp-json\/wp\/v2\/media?parent=1807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}